Medico Remedies (NSE:MEDICO) Beneish M-Score: -1.77 (As of Jun. 26, 2026)


NSE:MEDICO Medico Remedies Ltd NSE:MEDICO
86 GF Score
Price ₹40.28
GF Value ₹75.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medico Remedies Beneish M-Score?

Medico Remedies NSE:MEDICO -1.88% 86 Beneish M-Score is -1.77 as of Jun. 26, 2026. GuruFocus rates NSE:MEDICO with a GF Score™ of 86/100 and a GF Value™ of ₹75.89 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 911 Drug Manufacturers companies, Medico Remedies ranks worse than 85.29% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.77 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Medico Remedies's Beneish M-Score or its related term are showing as below:

NSE:MEDICO' s Beneish M-Score Range Over the Past 10 Years
Min: -2.81   Med: -2.09   Max: -1.66
Current: -1.77

During the past 13 years, the highest Beneish M-Score of Medico Remedies was -1.66. The lowest was -2.81. And the median was -2.09.


Medico Remedies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medico Remedies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies Beneish M-Score Chart

Medico Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 -2.41 -1.66 -2.42 -1.77

Medico Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 0.00 0.00 0.00 -1.77

NSE:MEDICO vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medico Remedies Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medico Remedies's Beneish M-Score falls into.


NSE:MEDICO
86GF Score
Medico Remedies Ltd NSE:MEDICO
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medico Remedies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medico Remedies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0489+0.528 * 1.0583+0.404 * 0.828+0.892 * 1.3673+0.115 * 1.0322
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.047202-0.327 * 1.0615
=-1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹823 Mil.
Revenue was ₹2,064 Mil.
Gross Profit was ₹550 Mil.
Total Current Assets was ₹1,289 Mil.
Total Assets was ₹1,534 Mil.
Property, Plant and Equipment(Net PPE) was ₹229 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹31 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹776 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3 Mil.
Net Income was ₹131 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹59 Mil.
Total Receivables was ₹574 Mil.
Revenue was ₹1,509 Mil.
Gross Profit was ₹426 Mil.
Total Current Assets was ₹967 Mil.
Total Assets was ₹1,198 Mil.
Property, Plant and Equipment(Net PPE) was ₹217 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹30 Mil.
Selling, General, & Admin. Expense(SGA) was ₹107 Mil.
Total Current Liabilities was ₹570 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(822.749 / 2063.773) / (573.709 / 1509.406)
=0.398663 / 0.380089
=1.0489

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(426.11 / 1509.406) / (550.497 / 2063.773)
=0.282303 / 0.266743
=1.0583

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1289.176 + 229.491) / 1534.033) / (1 - (966.751 + 216.749) / 1197.993)
=0.010017 / 0.012098
=0.828

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2063.773 / 1509.406
=1.3673

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(30.301 / (30.301 + 216.749)) / (30.946 / (30.946 + 229.491))
=0.122651 / 0.118823
=1.0322

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 2063.773) / (106.757 / 1509.406)
=0 / 0.070728
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.863 + 776.426) / 1534.033) / ((3.688 + 569.615) / 1197.993)
=0.508 / 0.478553
=1.0615

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(131.152 - 0 - 58.742) / 1534.033
=0.047202

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medico Remedies has a M-score of -1.77 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.77 mean?
Medico Remedies (NSE:MEDICO) has a Beneish M-Score of -1.77 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medico Remedies and its competitors. According to the industry distribution chart, Medico Remedies ranks #777 out of 911 companies in the Drug Manufacturers industry, placing it in the top 85.3%.
Is Medico Remedies' Beneish M-Score too high?
Medico Remedies' current Beneish M-Score is -1.77. Based on the distribution chart, Medico Remedies ranks #777 out of 911 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medico Remedies has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medico Remedies ranks #777 out of 911 companies for Beneish M-Score. This places Medico Remedies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medico Remedies and its competitors. Medico Remedies's current Beneish M-Score is -1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹75.89, compared to a current price of ₹40.28 — trading 46.9% below its estimated fair value. The current Beneish M-Score is -1.77. Medico Remedies' overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Beneish M-Score is -1.77 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?

Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued. The current stock price of ₹40.28 is trading 46.9% below its estimated GF Value™ of ₹75.89. GuruFocus considers Medico Remedies to be Significantly Undervalued.

Key valuation signals for NSE:MEDICO:

  • Beneish M-Score: -1.77
  • GF Value™: ₹75.89 vs. price of ₹40.28 (46.9% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medico Remedies Business Description

Other Exchanges 540937:India
Address N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
86GF Score

Get the complete analysis for NSE:MEDICO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.28
Price
₹75.89
GF Value